Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study

A 4-year prospective cohort study on patients with lung, gastric, hepatic, colorectal, breast, uterine, and ovarian cancer was conducted at the East-West Cancer Center (EWCC) of Daejeon Korean Medicine Hospital in Daejeon, Korea. We divided patients into 2 groups based on how long they had been rece...

Full description

Bibliographic Details
Main Authors: Su-Jung Ha PhD, Eunbin Kwag MS, Soodam Kim MS, Ji-Hye Park PhD, So-Jung Park PhD, Hwa-Seung Yoo PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-08-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354231154267
_version_ 1797733394060148736
author Su-Jung Ha PhD
Eunbin Kwag MS
Soodam Kim MS
Ji-Hye Park PhD
So-Jung Park PhD
Hwa-Seung Yoo PhD
author_facet Su-Jung Ha PhD
Eunbin Kwag MS
Soodam Kim MS
Ji-Hye Park PhD
So-Jung Park PhD
Hwa-Seung Yoo PhD
author_sort Su-Jung Ha PhD
collection DOAJ
description A 4-year prospective cohort study on patients with lung, gastric, hepatic, colorectal, breast, uterine, and ovarian cancer was conducted at the East-West Cancer Center (EWCC) of Daejeon Korean Medicine Hospital in Daejeon, Korea. We divided patients into 2 groups based on how long they had been receiving TKM oncotherapy and compared event-free survival (EFS), telomere length change, and quality of life (QoL). The study collected data on 83 patients from October 2016 to June 2020 and discovered no statistical differences in EFS based on the duration of TKM oncotherapy. In the analysis of changes in QoL outcomes, there were no statistically significant group differences between the groups. After controlling for covariates that could affect telomere length, the long-term TKM oncotherapy group had a higher daily telomere attrition rate. The study of the relationship between telomere length and prognostic factors discovered that patients with advanced N stage at the time of diagnosis and who had previously received radiotherapy had shorter telomere length. When examining associations between SNP genotype and percentile score of telomere length, this study was able to confirm an association between telomere length and rs4387287. This study is significant because it is the first to assess the effects of TKM oncotherapy and investigate telomere length-related factors. To assess the effects of TKM oncotherapy on cancer patients’ survival and QoL, a longer-term observational study with a larger sample size is required.
first_indexed 2024-03-12T12:28:28Z
format Article
id doaj.art-270046f56d2540bc93493bfd3641eb27
institution Directory Open Access Journal
issn 1552-695X
language English
last_indexed 2024-03-12T12:28:28Z
publishDate 2023-08-01
publisher SAGE Publishing
record_format Article
series Integrative Cancer Therapies
spelling doaj.art-270046f56d2540bc93493bfd3641eb272023-08-29T18:24:21ZengSAGE PublishingIntegrative Cancer Therapies1552-695X2023-08-012210.1177/15347354231154267Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort StudySu-Jung Ha PhD0Eunbin Kwag MS1Soodam Kim MS2Ji-Hye Park PhD3So-Jung Park PhD4Hwa-Seung Yoo PhD5Daejeon University, Daejeon City, Republic of KoreaDaejeon University, Daejeon City, Republic of KoreaMemorial Sloan Kettering Cancer Center, New York, NY, USADaejeon University, Seoul, Republic of KoreaPusan National University Yangsan-si, Gyeongsangnam-do, Republic of KoreaDaejeon University, Seoul, Republic of KoreaA 4-year prospective cohort study on patients with lung, gastric, hepatic, colorectal, breast, uterine, and ovarian cancer was conducted at the East-West Cancer Center (EWCC) of Daejeon Korean Medicine Hospital in Daejeon, Korea. We divided patients into 2 groups based on how long they had been receiving TKM oncotherapy and compared event-free survival (EFS), telomere length change, and quality of life (QoL). The study collected data on 83 patients from October 2016 to June 2020 and discovered no statistical differences in EFS based on the duration of TKM oncotherapy. In the analysis of changes in QoL outcomes, there were no statistically significant group differences between the groups. After controlling for covariates that could affect telomere length, the long-term TKM oncotherapy group had a higher daily telomere attrition rate. The study of the relationship between telomere length and prognostic factors discovered that patients with advanced N stage at the time of diagnosis and who had previously received radiotherapy had shorter telomere length. When examining associations between SNP genotype and percentile score of telomere length, this study was able to confirm an association between telomere length and rs4387287. This study is significant because it is the first to assess the effects of TKM oncotherapy and investigate telomere length-related factors. To assess the effects of TKM oncotherapy on cancer patients’ survival and QoL, a longer-term observational study with a larger sample size is required.https://doi.org/10.1177/15347354231154267
spellingShingle Su-Jung Ha PhD
Eunbin Kwag MS
Soodam Kim MS
Ji-Hye Park PhD
So-Jung Park PhD
Hwa-Seung Yoo PhD
Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
Integrative Cancer Therapies
title Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
title_full Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
title_fullStr Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
title_full_unstemmed Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
title_short Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
title_sort effect of traditional korean medicine oncotherapy on the survival quality of life and telomere length a prospective cohort study
url https://doi.org/10.1177/15347354231154267
work_keys_str_mv AT sujunghaphd effectoftraditionalkoreanmedicineoncotherapyonthesurvivalqualityoflifeandtelomerelengthaprospectivecohortstudy
AT eunbinkwagms effectoftraditionalkoreanmedicineoncotherapyonthesurvivalqualityoflifeandtelomerelengthaprospectivecohortstudy
AT soodamkimms effectoftraditionalkoreanmedicineoncotherapyonthesurvivalqualityoflifeandtelomerelengthaprospectivecohortstudy
AT jihyeparkphd effectoftraditionalkoreanmedicineoncotherapyonthesurvivalqualityoflifeandtelomerelengthaprospectivecohortstudy
AT sojungparkphd effectoftraditionalkoreanmedicineoncotherapyonthesurvivalqualityoflifeandtelomerelengthaprospectivecohortstudy
AT hwaseungyoophd effectoftraditionalkoreanmedicineoncotherapyonthesurvivalqualityoflifeandtelomerelengthaprospectivecohortstudy